Reinsurance articles

Technology supply-chain dependencies get treated as isolated vendor risk, when they actually behave as a shared concentration exposure across an entire portfolio.

2026-09-08

Boards need an explicit risk-appetite test for technology supply-chain dependencies before regulators or a real outage force the question onto the agenda.

2026-09-08

Technology supply-chain dependencies force a specific set of executive committee questions before renewal season, not after a correlated loss forces the answer.

2026-09-08

Technology supply-chain dependencies turn a single vendor outage into a correlated loss event that shows up directly in reinsurance earnings volatility.

2026-09-08

Treaty recapture decisions without customer impact analysis carry a measurable balance-sheet cost, from solvency ratio erosion to reserve strain. Here is how to size it.

2026-09-08

Treaty recapture decisions without customer impact analysis reach the P&L when operating controls are missing. Here are five control points that catch the risk earlier.

2026-09-08

Treaty recapture decisions without customer impact analysis expose reinsurers and cedants to hidden servicing and capital risk. Here is what leaders need to diagnose first.

2026-09-08

Board oversight of treaty recapture decisions without customer impact analysis needs a renewal-season stress test. Here is what that test should cover.

2026-09-08

Treaty recapture decisions without customer impact analysis are not a treasury matter alone. Here is why CEOs and CUOs need to own this on the executive agenda.

2026-09-08

Underwriting evidence that ages too quickly is an operating-controls problem as much as a data problem. Here is how better workflow design closes the gap for reinsurers.

2026-09-08

Underwriting evidence that ages too quickly does not just create a diagnosis problem, it quietly erodes margin and distorts capital across a reinsurance treaty. Here is how to size that cost.

2026-09-08

Underwriting evidence that ages too quickly deserves a standing board-level scenario, not a one-time review. Here is the exercise reinsurance leaders should run and repeat.

2026-09-08

Underwriting evidence that ages too quickly is a growing risk-diagnosis problem for life and health reinsurers. Here is why point-in-time evidence stops describing the applicant almost immediately, and what that means for treaty risk.

2026-09-08

Underwriting evidence that ages too quickly needs a clear decision owner. Here is the executive decision framework reinsurers need to control this exposure before it becomes a renewal surprise.

2026-09-08

API gaps broker cedant systems impact goes beyond slow processing, distorting pricing accuracy and hiding true portfolio profitability.

2026-09-01

API gaps broker cedant systems management does not require a full platform rebuild, targeted integration on the highest-volume flows closes most of the gap.

2026-09-01

API gaps broker cedant systems oversight starts with putting a real number on how much placement speed and pricing accuracy the current process actually costs.

2026-09-01

API gaps broker cedant systems strategy questions belong in front of the executive committee, because they touch distribution speed, pricing, and technology spend at once.

2026-09-01